Showing 12,001 - 12,020 results of 152,588 for search '(( a we decrease ) OR ( 5 ((ng decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.01s Refine Results
  1. 12001
  2. 12002

    RORγt-expressing cells attenuate cardiac remodeling after myocardial infarction by Daichi Enomoto (4379605)

    Published 2017
    “…Finally, the mRNA expression of RORγt, IL-17A, IL-17F and IL-23 receptor (IL-23R) mRNA and protein expression of IL-10 were decreased in RORγt<sup>+/-</sup> hearts.…”
  3. 12003
  4. 12004
  5. 12005

    Data_Sheet_1_Expression and Functional Analysis of lncRNAs Involved in Platelet-Derived Growth Factor-BB-Induced Proliferation of Human Aortic Smooth Muscle Cells.PDF by Jia-Jie Lin (11398619)

    Published 2021
    “…One of the upregulated lncRNAs in proliferative HASMC was HIF1A anti-sense RNA 2 (HIF1A-AS2). HIF1A-AS2 suppression decreased HASMC proliferation via the miR-30e-5p/CCND2 mRNA axis. …”
  6. 12006

    Table_1_Expression and Functional Analysis of lncRNAs Involved in Platelet-Derived Growth Factor-BB-Induced Proliferation of Human Aortic Smooth Muscle Cells.XLS by Jia-Jie Lin (11398619)

    Published 2021
    “…One of the upregulated lncRNAs in proliferative HASMC was HIF1A anti-sense RNA 2 (HIF1A-AS2). HIF1A-AS2 suppression decreased HASMC proliferation via the miR-30e-5p/CCND2 mRNA axis. …”
  7. 12007

    Image_1_Expression and Functional Analysis of lncRNAs Involved in Platelet-Derived Growth Factor-BB-Induced Proliferation of Human Aortic Smooth Muscle Cells.tif by Jia-Jie Lin (11398619)

    Published 2021
    “…One of the upregulated lncRNAs in proliferative HASMC was HIF1A anti-sense RNA 2 (HIF1A-AS2). HIF1A-AS2 suppression decreased HASMC proliferation via the miR-30e-5p/CCND2 mRNA axis. …”
  8. 12008

    Table_2_Expression and Functional Analysis of lncRNAs Involved in Platelet-Derived Growth Factor-BB-Induced Proliferation of Human Aortic Smooth Muscle Cells.XLS by Jia-Jie Lin (11398619)

    Published 2021
    “…One of the upregulated lncRNAs in proliferative HASMC was HIF1A anti-sense RNA 2 (HIF1A-AS2). HIF1A-AS2 suppression decreased HASMC proliferation via the miR-30e-5p/CCND2 mRNA axis. …”
  9. 12009

    Differences in abundance of non-lipid molecules in liver of <i>Fmo5</i><sup><i>-/-</i></sup> and WT mice. by Ian R. Phillips (5074121)

    Published 2023
    “…Red dots are non-lipids that are significantly increased or decreased in <i>Fmo5</i><sup><i>-/-</i></sup> mice with a -log<sub>10</sub> <i>q</i> above 1.301 (<i>q</i> <0.05) (grey line). …”
  10. 12010

    S1 Data - by Estibaliz Castillero (393067)

    Published 2024
    “…We analyzed SSTR in cardiac samples from patients with end-stage ischemic cardiomyopathy (ICM, n = 8) and control hearts (n = 5). …”
  11. 12011
  12. 12012
  13. 12013

    Differences in abundance of lipid molecules in liver of <i>Fmo5</i><sup><i>-/-</i></sup> and WT mice. by Ian R. Phillips (5074121)

    Published 2023
    “…Red dots are lipids that are significantly increased or decreased in <i>Fmo5</i><sup><i>-/-</i></sup> mice with a -log<sub>10</sub> <i>q</i> above 1.301 (<i>q</i> <0.05) (grey line). …”
  14. 12014

    The data of meta-analysis. by Fei Lin (156666)

    Published 2023
    “…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
  15. 12015

    Quality assessment for risk of bias for studies. by Fei Lin (156666)

    Published 2023
    “…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
  16. 12016

    Effect of tirzepatide vs placebo on body weight. by Fei Lin (156666)

    Published 2023
    “…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
  17. 12017

    The results of safety in meta-analysis. by Fei Lin (156666)

    Published 2023
    “…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
  18. 12018

    Graphs of risk of bias for studies. by Fei Lin (156666)

    Published 2023
    “…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
  19. 12019

    General baseline of included studies. by Fei Lin (156666)

    Published 2023
    “…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
  20. 12020